Sam Brusco, Associate Editor09.13.22
Johnson & Johnson Vision has launched its new AcuVue Oasys Max 1-Day contact lenses and AcuVue Oasys Max 1-Day Multifocal contact lenses for presbyopia.
The new lenses feature TearStable, designed to maximize tear-film stability and lock in moisture for all-day comfort.1,2 They also have the company’s OptiBlue blue-violet light filter to reduce light scatter day and night.2
"Life has changed, post-pandemic. With more time spent on digital devices,3 we designed these contact lenses by listening to patients and eye care professionals' feedback to address lifestyle requirements and help prevent dry and tired eyes from becoming normalized," John Buch, OD, Senior Principal Research Optometrist, Johnson & Johnson Vision, told the press. "Our new AcuVue Oasys Max 1-Day contact lenses help reduce discomfort by providing visual clarity with new technologies to filter blue-violet light, which comes from many sources, including digital screens and travels in short wavelengths and scatters more which can lead to eye discomfort and quality of vision."4
The lenses were engineered to account for the over 12 hours many adults spend looking at a screen, which can impact visual clarity.
"I've witnessed more patients facing symptoms related to a destabilized tear film such as dryness and inconsistent vision due to our increasingly digital lifestyles. It's important for all contact lens users to have the latest innovative treatment options available to help address comfort and clarity to meet their lifestyle requirements," said Luis Rojas, OD, co-founder of DeNovo Eye. " AcuVue Oasys Max 1-Day uses innovative technology, designed to maximize tear film stability and reduce light scatter to maintain increased visual clarity and all-day comfort."1,2,5
Earlier this year, AcuVue Oasys Max 1-Day and AcuVue Oasys Max 1-Day Multifocal received U.S. Food & Drug Administration (FDA) clearance.
References
1 JJV Data on File 2022. TearStable Technology Definition.
2 JJV Data on File, 2022. CSM Subjective Responses ACUVUE OASYS MAX 1-Day Contact Lenses- Retrospective Meta-analysis.
3 COVID-19: Screen Time spikes to over 13 hours per day according to Eyesafe Nielsen estimates, published 3/28/20, https://eyesafe.com/covid-19-screen-time-spike-to-over-13-hours-per-day3.
4 JJV Data on File 2022. Blue-Violet Filter Utilized in ACUVUE OASYS MAX 1-Day Contact Lenses.
5 JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts with ACUVUE OASYS MAX 1-Day Family.
The new lenses feature TearStable, designed to maximize tear-film stability and lock in moisture for all-day comfort.1,2 They also have the company’s OptiBlue blue-violet light filter to reduce light scatter day and night.2
"Life has changed, post-pandemic. With more time spent on digital devices,3 we designed these contact lenses by listening to patients and eye care professionals' feedback to address lifestyle requirements and help prevent dry and tired eyes from becoming normalized," John Buch, OD, Senior Principal Research Optometrist, Johnson & Johnson Vision, told the press. "Our new AcuVue Oasys Max 1-Day contact lenses help reduce discomfort by providing visual clarity with new technologies to filter blue-violet light, which comes from many sources, including digital screens and travels in short wavelengths and scatters more which can lead to eye discomfort and quality of vision."4
The lenses were engineered to account for the over 12 hours many adults spend looking at a screen, which can impact visual clarity.
"I've witnessed more patients facing symptoms related to a destabilized tear film such as dryness and inconsistent vision due to our increasingly digital lifestyles. It's important for all contact lens users to have the latest innovative treatment options available to help address comfort and clarity to meet their lifestyle requirements," said Luis Rojas, OD, co-founder of DeNovo Eye. " AcuVue Oasys Max 1-Day uses innovative technology, designed to maximize tear film stability and reduce light scatter to maintain increased visual clarity and all-day comfort."1,2,5
Earlier this year, AcuVue Oasys Max 1-Day and AcuVue Oasys Max 1-Day Multifocal received U.S. Food & Drug Administration (FDA) clearance.
References
1 JJV Data on File 2022. TearStable Technology Definition.
2 JJV Data on File, 2022. CSM Subjective Responses ACUVUE OASYS MAX 1-Day Contact Lenses- Retrospective Meta-analysis.
3 COVID-19: Screen Time spikes to over 13 hours per day according to Eyesafe Nielsen estimates, published 3/28/20, https://eyesafe.com/covid-19-screen-time-spike-to-over-13-hours-per-day3.
4 JJV Data on File 2022. Blue-Violet Filter Utilized in ACUVUE OASYS MAX 1-Day Contact Lenses.
5 JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts with ACUVUE OASYS MAX 1-Day Family.